ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024

31 окт 2024 04:00:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

17 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024

03 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update

06 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024

01 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference

30 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire

Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference

28 июл 2024 17:00:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

20 июн 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences Announces Expansion of Leadership Team

22 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

14 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

09 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

02 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

25 апр 2024 09:45:15 Источник NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

24 апр 2024 09:50:00 Источник NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

19 апр 2024 09:45:15 Источник NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

18 апр 2024 10:01:00 Источник NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

17 апр 2024 13:00:01 Источник NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

16 апр 2024 09:45:05 Источник NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

12 апр 2024 15:38:10 Источник NetDania Notify

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

11 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire